African health sciences
-
African health sciences · Jun 2023
Meta AnalysisGarlic supplementation for the treatment of chronic liver disease: a meta-analysis of randomized controlled trials.
The efficacy of garlic supplementation for chronic liver disease remains controversial. We conduct a meta-analysis to explore the influence of garlic supplementation versus placebo on the treatment of chronic liver disease. ⋯ Garlic supplementation is effective to treat chronic liver disease.
-
African health sciences · Jun 2023
Heart failure in Nigeria: protocol for a systematic review and meta-analysis.
Heart failure is now a significant contributor to the burden of non-communicable diseases in developing countries like Nigeria which is experiencing epidemiologic and demographic transition. The epidemiology of heart failure in this country is poorly characterized. The aim of the review is to determine the prevalence of heart failure, the associated risk factors, the aetiology, management, and outcomes of the condition in the country. ⋯ This will be the first systematic review and meta-analysis of heart failure epidemiology in Nigeria which will hopefully identify gaps for future research and guidance for policy interventions.
-
African health sciences · Jun 2023
Meta AnalysisEmricasan for the treatment of liver cirrhosis: a meta-analysis of randomized controlled trials.
The efficacy of emricasan for liver cirrhosis remains controversial. We conduct a systematic review and meta-analysis to explore the influence of emricasan versus placebo on the treatment of liver cirrhosis. ⋯ Emricasan treatment provided no benefit for the treatment of liver cirrhosis.
-
African health sciences · Jun 2023
Meta AnalysisTherapeutic outcome of dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
The efficacy of dapagliflozin remains controversial for patients with type 2 diabetes and non-alcoholic fatty liver disease. We conduct this meta-analysis to explore the influence of dapagliflozin versus placebo on the treatment efficacy of type 2 diabetes complicated with non-alcoholic fatty liver disease. ⋯ Dapagliflozin benefits to improve hepatic function and glucose control in patients with type 2 diabetes and non-alcoholic fatty liver disease, as evidenced by the reduction in ALT, AST, fasting glucose and HbA1c.
-
African health sciences · Jun 2023
Exclusive breastfeeding knowledge and practice among nursing mothers in selected healthcare facilities in Kaduna Metropolis, Nigeria.
Exclusive breast feeding (EBF) in the first six months of life is recognized as an indispensable component of survival, physical and mental development of children. Despite the enormous benefits of EBF, only 39% of infants less than 6 months of age are exclusively breastfed globally. ⋯ Findings from this study showed that most of the participants had a very good knowledge of EBF and are practicing it.